IP Library Granted Patent US 7,825,091
Granted Patent B2
US 7,825,091 · App. 11/781,773 · Granted Nov 2, 2010

Modification of feeding behaviour

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,825,091
App. No.
11/781,773
Granted
Nov 2, 2010
Kind
B2
Abstract

The present invention relates to compositions and methods for use in the prevention or treatment of excess weight in a mammal. The compositions comprise oxyntomodulin which is shown to reduce food intake and/or increase energy expenditure.

Claims (13)

1. A method for the prevention or treatment of excess weight in a subject mammal, which comprises administering oxyntomodulin and PYY to the subject.

2. The method according to claim 1 , which is a method for the reduction or prevention of obesity.

3. The method according to claim 1 , which comprises administering PYY 3-36 .

4. The method according to claim 1 , wherein the oxyntomodulin is administered via a route peripheral to the brain.

5. The method according to claim 1 , wherein the PYY is administered via a route peripheral to the brain.

6. The method according to claim 4 , wherein the oxyntomodulin is administered by a route selected from the group consisting of oral, rectal, intravenous, intramuscular, intraperitoneal, buccal, sublingual, nasal, subcutaneous, and transdermal administration.

7. The method according to claim 5 , wherein the PYY is administered by a route selected from the group consisting of oral, rectal, intravenous, intramuscular, intraperitoneal, buccal sublingual, nasal, subcutaneous, and transdermal administration.

8. The method according to claim 1 , wherein the oxyntomodulin is administered peripherally at a dose of 0.1 nmoles or more per kg body weight of the subject.

9. The method according to claim 1 , wherein the oxyntomodulin is administered peripherally at a dose of up to 12 nmoles per kg body weight.

10. The method according to claim 1 , wherein the oxyntomodulin is administered at a dose of 0.5 mg to 2 mg before meals.

11. The method according to claim 1 , wherein the PYY is administered peripherally at a dose of 0.1 nmoles per kg body weight of the subject or more.

12. The method according to claim 1 , wherein the PYY is administered peripherally at a dose of up to 3.2 nmoles per kg body weight.

13. The method according to claim 1 , wherein the oxyntomodulin and the PYY are administered simultaneously, or sequentially in any order.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2007
From: BLOOM, STEPHEN ROBERT; GHATEI, MOHAMMAD ALI; SMALL, CAROLINE JANE; DAKIN, CATHERINE LOUISE
To: IMPERIAL COLLEGE INNOVATIONS LIMITED
Reel/Frame 019886/0551 →
CHANGE OF NAME Recorded Sep 26, 2007
From: IMPERIAL COLLEGE INNOVATIONS LIMITED
To: IMPERIAL INNOVATIONS LIMITED
Reel/Frame 019886/0683 →